Bellicum Pharmaceuticals, Inc. announced executive changes. Effective January 17, 2020, Rosemary Williams’ employment as the Company’s Vice President of Finance and Controller will terminate. Subject to Ms. Williams’s continued employment through January 17, 2020 and in exchange for a full general release of claims and continued compliance with her employment agreement, Ms. Williams will receive: salary continuation for six months following the Separation Date; a lump sum cash payment equal to Ms. Williams’s pro-rated target bonus for 2020; and COBRA payments for up to six months. In connection with Ms. Williams’s departure, the Company has appointed David E. Strauss, to serve as Director, Corporate Controller, effective as of January 8, 2020. Prior to joining the Company, Mr. Strauss served as Corporate Controller of Landec Corporation, beginning in March 2019.